We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.31% |
| 2 | Technology | 14.86% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Healthcare | 10.93% |
| 5 | Communication Services | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Alarm.com
ALRM
$2.83B
| $92.1M | 0.2% |
1,418,385
+30,954
| +2% | +$1.88M |
2017 Q3
6 quarters
|
|
102
DELISTED
Electronic Arts
EA
| $91.7M | 0.2% |
902,514
-900,368
| -50% | -$85.3M |
2017 Q3
6 quarters
|
|
103
Adobe
ADBE
$97.9B
| $88.6M | 0.19% |
332,320
-16,778
| -5% | -$4.23M |
2017 Q3
6 quarters
|
|
104
Prologis
PLD
$121B
| $87.8M | 0.19% |
1,220,639
-54,234
| -4% | -$3.7M |
2017 Q3
6 quarters
|
|
105
Gilead Sciences
GILD
$195B
| $86.8M | 0.19% |
1,334,356
+23,848
| +2% | +$1.59M |
2017 Q3
6 quarters
|
|
106
Intuit
INTU
$88.2B
| $86.7M | 0.19% |
331,448
+51,474
| +18% | +$11.9M |
2017 Q3
6 quarters
|
|
107
S&P Global
SPGI
$125B
| $86.2M | 0.19% |
409,476
-115,472
| -22% | -$22.4M |
2017 Q3
6 quarters
|
|
|
PRAH
108
DELISTED
PRA Health Sciences, Inc.
PRAH
| $85.3M | 0.18% |
773,818
-33,774
| -4% | -$3.53M |
2018 Q1
4 quarters
|
|
109
ConocoPhillips
COP
$170B
| $82.6M | 0.18% |
1,237,111
-197,636
| -14% | -$13.3M |
2017 Q3
6 quarters
|
|
110
Altria Group
MO
$123B
| $81.4M | 0.18% |
1,417,996
-337,493
| -19% | -$17.2M |
2017 Q3
6 quarters
|
|
111
Lowe's Companies
LOW
$110B
| $81.4M | 0.18% |
743,832
+24,321
| +3% | +$2.43M |
2017 Q3
6 quarters
|
|
112
Elevance Health
ELV
$92.9B
| $81.3M | 0.18% |
283,323
-343,711
| -55% | -$99.4M |
2017 Q3
6 quarters
|
|
113
Simon Property Group
SPG
$65.8B
| $77.9M | 0.17% |
427,540
-1,616
| -0.4% | -$287K |
2017 Q3
6 quarters
|
|
114
Trip.com Group
TCOM
$25.1B
| $75.7M | 0.16% |
1,732,350
-1,633,983
| -49% | -$57.3M |
2017 Q3
6 quarters
|
|
115
RB Global
RBA
$16.1B
| $75.1M | 0.16% |
2,207,642
+128,182
| +6% | +$4.52M |
2017 Q3
6 quarters
|
|
116
Aflac
AFL
$59.2B
| $74.2M | 0.16% |
1,483,780
-527,241
| -26% | -$25.4M |
2017 Q3
6 quarters
|
|
117
Sociedad Química y Minera de Chile
SQM
$17.3B
| $73.9M | 0.16% |
1,921,300
-5,700
| -0.3% | -$233K |
2017 Q4
5 quarters
|
|
|
FDC
118
DELISTED
First Data Corporation
FDC
| $73.8M | 0.16% |
2,807,047
-4,577,407
| -62% | -$109M |
2017 Q3
6 quarters
|
|
119
AbbVie
ABBV
$501B
| $72M | 0.16% |
893,887
+120,383
| +16% | +$9.85M |
2017 Q3
6 quarters
|
|
120
Baidu
BIDU
$28.1B
| $71.5M | 0.15% |
433,790
+3,317
| +0.8% | +$555K |
2017 Q3
6 quarters
|
|
121
Credicorp
BAP
$30.8B
| $71.3M | 0.15% |
297,068
-1,708
| -0.6% | -$407K |
2017 Q3
6 quarters
|
|
122
Salesforce
CRM
$203B
| $70.5M | 0.15% |
444,753
+209,161
| +89% | +$32.4M |
2017 Q3
6 quarters
|
|
|
MDP
123
DELISTED
Meredith Corporation
MDP
| $68.1M | 0.15% |
1,232,134
+168,887
| +16% | +$9.38M |
2017 Q3
6 quarters
|
|
124
Dominion Energy
D
$55.3B
| $66.8M | 0.14% |
870,903
+580,105
| +199% | +$42.4M |
2017 Q3
6 quarters
|
|
125
Abbott
ABT
$181B
| $66M | 0.14% |
824,791
+194,666
| +31% | +$14.5M |
2017 Q3
6 quarters
|
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.